The Clorox Company $CLX Shares Purchased by Mengis Capital Management Inc.

Mengis Capital Management Inc. grew its holdings in shares of The Clorox Company (NYSE:CLX) by 38.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 47,643 shares of the company’s stock after buying an additional 13,260 shares during the quarter. Mengis Capital Management Inc.’s holdings in Clorox were worth $4,804,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the business. Haverford Trust Co lifted its holdings in shares of Clorox by 2.8% during the 4th quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock valued at $310,000 after acquiring an additional 84 shares in the last quarter. Field & Main Bank boosted its position in Clorox by 3.3% during the 4th quarter. Field & Main Bank now owns 3,100 shares of the company’s stock worth $313,000 after purchasing an additional 100 shares during the period. Golden State Wealth Management LLC increased its holdings in Clorox by 28.2% in the 4th quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock valued at $46,000 after purchasing an additional 100 shares in the last quarter. Fisher Asset Management LLC increased its holdings in Clorox by 1.7% in the 3rd quarter. Fisher Asset Management LLC now owns 6,053 shares of the company’s stock valued at $746,000 after purchasing an additional 102 shares in the last quarter. Finally, Johnson Financial Group Inc. raised its position in Clorox by 3.1% in the third quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company’s stock valued at $451,000 after purchasing an additional 109 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

CLX has been the topic of a number of recent research reports. BNP Paribas Exane reduced their price objective on Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 12th. JPMorgan Chase & Co. lowered their target price on Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday, May 1st. Barclays dropped their target price on Clorox from $102.00 to $85.00 and set an “underweight” rating on the stock in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $91.00 price target on shares of Clorox in a research report on Friday, May 1st. Finally, Weiss Ratings raised shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, April 13th. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Reduce” and an average target price of $103.40.

Clorox Trading Up 0.1%

CLX opened at $95.90 on Friday. The stock has a market capitalization of $11.60 billion, a PE ratio of 15.57, a P/E/G ratio of 0.50 and a beta of 0.56. The firm’s fifty day moving average price is $95.71 and its 200 day moving average price is $104.82. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $132.03.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm’s revenue was up .1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, research analysts expect that The Clorox Company will post 5.61 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Pierre R. Breber purchased 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 5th. The stock was acquired at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.63% of the company’s stock.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.